
Drug Target Models
GPCR Reporter Cells
Immunotherapy cells
Other Stable Cells
Assay Kits & Reagents
Services
Resources
Company
Cat. No: RQP74146
Size: 1 vial of frozen cells (>1E6 per vial in 1 mL)
Unit Price: Contact For Pricing
| Cat. No | RQP74146 |
| Product Name | Raji Human PDL1 MHCII APC Cell |
| Product Type | Reporter Cell |
| Culture Properties | suspension |
| Stability | 32passages (in-house test, that not means the cell line will be instable beyond the passages we tested.) |
| Mycoplasma Status | Negative |
| Culture Medium | RPMI-1640+10%FBS+1μg/ml puromycin |
| Freeze Medium | 90% FBS+10% DMSO |
| Storage Conditions | Liquid nitrogen immediately upon delivery |
| Application | Functional(Report Gene) Assay |
For research use only. Not intended for human or animal clinical trials, therapeutic or diagnostic use.
Programmed Cell Death Protein 1 (PD-1), a receptor expressed on activated T cells, binds to its ligands PD-L1 and PD-L2 to negatively regulate immune responses. PD-1 ligands are present in most cancers, and the PD-1:PD-L1/2 interaction inhibits T cell activity, allowing cancer cells to evade immune surveillance. The PD1/PDL1 signaling pathway is an important component of tumor immune suppression, as it can inhibit T lymphocyte activation, enhance tumor cell immune tolerance, and thereby enable tumor immune escape.
Raji Human PDL1 MHCII APC Cell stably express human PDL1 based on Raji .

Figure 1. Recombinant PDL1/MHCII APC Cell constitutively expressing PDL1.
| Classification | Combination |
| Family | B7 family |
| Gene Name | CD274 |
| Gene Aliases | B7-H;B7H1;PD-L1;B7-H1;PDCD1LG1;PDCD1L1 |
| Gene ID | 29126 |
| Accession Number | NM_014143.4 |
| UniProt Number | Q9NZQ7 |
| Protein Name | PD-L1;PDCD1 ligand 1; Programmed death ligand 1; hPD-L1 |
| Protein Aliases | B7-H1; |
| Target Species | Human |
| Host cell | Raji |

Figure 2. Dose Response of Blocking Antibodies in PD-1/LAG3 Dual Effector Reporter Cells (C15) with PD-L1/MHCII APC Cells.
Cell Passage Procedures
1.This cell line grows in suspension.
2.Upon receipt, cells should be thawed immediately or stored in liquid nitrogen until use.
3.Before thawing, pre-warm the water bath and culture medium to 37 °C, and prepare a small amount of dry ice.
4.Remove the cryovial from storage and transport it to the cell culture laboratory on dry ice.
5.Rapidly thaw the cells in a 37 °C water bath. Once the cells are completely thawed, spray the cryovial with 70% ethanol for disinfection and transfer it to a biosafety cabinet.
6.Add 10 mL of pre-warmed culture medium into a 15 mL centrifuge tube. Transfer the contents of the cryovial into the tube and centrifuge at 1000 rpm for 5 minutes.
7.Carefully discard the supernatant. Resuspend the cell pellet in 5 mL of pre-warmed culture medium by gentle pipetting. Immediately perform cell counting and adjust the cell density to 3–6 × 10⁵ cells/mL based on the counting results, then transfer the cells into a culture flask.
8.Count the cells every 1–2 days. When the cell density exceeds 1 × 10⁶ cells/mL, passage the cells promptly or add fresh culture medium. Maintain the cell density between 2 × 10⁵ and 1 × 10⁶ cells/mL.
Suspension Cell Cryopreservation Procedure:
1.Collect 8 × 10⁶ cells, centrifuge, and discard the supernatant.
2.Add 1 mL of cell freezing medium (90% FBS + 10% DMSO) and gently pipette to mix thoroughly. Transfer the suspension into a cryovial.
3.Immediately place the cryovial into a controlled-rate freezing container (Nalgene 5100-0001), fill with isopropanol up to the indicated level, and store at −80 °C.
4.After 24 hours, transfer the cryovial to liquid nitrogen for long-term storage.
We Are Pleased to Announce: Global Commercial Licensing Rights for Jurkat E6.1, CHO-K1, and HEK293 Cell Lines Officially Secured.
Explore